Approval · Notice of Compliance 4420 · 1996
FROBEN: Notice of Compliance 4420
Issued June 18, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4420
- Date
- June 18, 1996
- Company
- Knoll Pharma Inc.Markham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Non-steroidal anti-inflammatory agent
Products in this notice
Medicinal ingredients
- FLURBIPROFEN 50 MG per TAB
- FLURBIPROFEN 100 MG per TAB
- FLURBIPROFEN 200 MG per CAP